Equity Research Associate, Healthcare

Wedbush; San Francisco (CA); On-site; USD 100,000 - 150,000; Full time

Benefits offered by this job

Medical, dental, and vision coverage

HSA with company contributions

FSA

401(k) matching

Tuition reimbursement

FINRA license sponsorship

Travel & Employee Assistance

Discretionary compensation

Job summary

Wedbush Securities seeks an Equity Research Associate to join its award-winning healthcare research team in San Francisco. You will analyze oncology, rare-disease, and platform-technology assets, translating science into investment theses and building robust financial models.

A strong scientific background and an eagerness to grow in high-stakes finance are essential. You will work closely with senior analysts, perform due diligence, and contribute to research notes while collaborating with

Qualifications

• Advanced degree in life sciences; MD/PhD preferred, bachelor’s required.
• Strong quantitative and analytical skills.
• Excellent verbal and written communication; detail oriented.

Responsibilities

• Conduct scientific and market due diligence on healthcare names.
• Interpret publications and conference data to inform investment theses.
• Build and update financial models and company databases.
• Assist with research notes and reports for the team.
• Interact with management and the sales force as needed.

Skills

Financial modeling

Quantitative analysis

Verbal & written communication

Independent & team work

Advanced Excel

Life sciences mindset

Education

Advanced life sciences degree

Bachelor's degree

Tools

Excel

Financial databases

Job description

We are seeking a driven Equity Research Associate to join our award-winning team of sell-side equity researchers covering the healthcare sector; one of the most dynamic and high-impact areas in today's capital markets.

This is a rare chance to work at the intersection of cutting-edge science and high-stakes finance, gaining direct exposure to groundbreaking oncology, rare-disease, and platform-technology innovation while building the analytical toolkit of a top-tier equity research professional. You will work shoulder-to-shoulder with some of the most respected minds in the industry, with a clear runway to grow your career, your network, and your impact on how institutional investors understand the future of medicine.

If you have a scientific mind, a competitive drive, and a passion for the markets, this is your opportunity to break into, or accelerate within one of the most intellectually rewarding corners of Wall Street.

Wedbush Securities is one of the largest securities firms and investment banks in the nation. We provide innovative financial solutions through our Wealth Management, Capital Markets, Futures and Advanced Clearing & Prime Services divisions. Headquartered in Los Angeles, California with over 100 offices and more than 80 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth.

Why Join Wedbush

• Work directly alongside an award-winning sell-side research team with deep relationships across the healthcare landscape
• Gain unmatched exposure to cutting‑edge science, from novel oncology mechanisms to rare‑disease breakthroughs and next‑generation therapeutic platforms
• Build a highly transferable, elite skill set in financial modeling, scientific due diligence, and institutional communication

What You Will Do

• Conduct regular scientific and market due diligence on covered companies, including channel checks on assigned names
• Interpret scientific publications and medical conference presentations to inform investment theses
• Conduct surveys with key medical opinion leaders to validate clinical and commercial assumptions
• Support coverage spanning oncology, rare-disease, and technology‑platform companies and their therapeutic assets
• Build, update, and maintain detailed financial models and company databases
• Conduct regular financial and market due diligence on covered companies
• Collect and analyze industry data and develop proprietary sector databases
• Assist with the timely preparation and publication of research notes and reports
• Interact with corporate management and our internal sales force
• Provide general support to the broader equity research team, including company research, industry due diligence, and special projects as assigned
• Perform other tasks and duties as required and assigned

Experience and Skills

• Advanced degree in life sciences (MD, PhD) preferred; Bachelor’s degree from an accredited university required
• Active FINRA Licenses including SIE, Series 86 & 87 preferred; will be required to obtain them within 120 days of start date if not currently active
• Superb quantitative and analytical skills
• Exceptionally strong verbal and written communication skills
• Ability to maintain a high degree of accuracy in a fast‑paced, deadline‑driven environment
• Ability to work independently and within a team, prioritizing daily workflow with little direction
• Advanced Excel skills essential; experience building financial models a plus
• Strong work ethic and a great attitude with an ability to perform duties under minimal supervision

What Wedbush Offers You

As part of our overall compensation package, Wedbush Securities offers an array of diverse benefits to all our colleagues. We believe that providing competitive benefit options yields the advantageous reward of establishing a healthy and inclusive foundational work culture.

• Comprehensive medical, dental, and vision coverage with multiple health plan options
• Health Savings Account (HSA) with company‑sponsored contributions
• Flexible Spending Accounts (FSA) traditional and dependent care
• 401(k) Plan: competitive discretionary company matching and profit‑sharing contributions
• Tuition reimbursement ($5,250 max per year)
• FINRA and Professional License Sponsorship
• Charitable Donation Matching Contributions
• Travel & Employee Assistance and Employee Discount Programs
• Discretionary compensation based on the colleague's and the firm's performance

The reasonable estimate of the compensation range for this role has not been adjusted for the applicable geographic location. A reasonable estimate of the current range is $100,000-$150,000 depending on experience. Colleagues may be eligible for additional, discretionary incentive compensation based on the colleague's and the firm's performance. At Wedbush, Decisions regarding compensation are determined on a case‑by‑case basis and are dependent on a variety of factors including but not limited to skill sets; experience and training; licensure and certifications; and other business and organizational needs.

Wedbush Securities (WS) is proud to be an Equal Employment Opportunity employer. WS does not discriminate based on race, religion, color, creed, sex, sexual orientation, gender, gender identity or expression, national origin, ancestry, citizenship status, registered domestic partner status, uniform service member status, marital status, pregnancy, age, medical condition, disability, genetic information, family care or medical leave status, or any other consideration made unlawful by applicable federal, state, or local laws, or on the basis that an applicant or Colleague is perceived to have these characteristics or is associated with someone who is perceived to have these characteristics. WS aims to foster a culture of inclusion where all Colleagues are valued for their unique contributions to the firm as well as provided equal opportunities to succeed.

Wedbush uses E‑Verify, an Internet‑based system, to confirm the eligibility of all newly hired employees to work in the United States. Learn more about E‑Verify, including your rights and responsibilities here https://www.e-verify.gov/employees/e-verify-overview

This position is subject to various laws or regulations that impose restrictions or prohibitions for employment with Wedbush due to criminal history. Those laws or regulations include but are not limited to, the following: Securities Exchange Act of 1934 (SEA) Rule 17a‑3, et. seq., Financial Industry Regulatory Authority (FINRA) Rules 3110(e), Rule 4530(a), etc., and FINRA Regulatory Notice 07‑55.